SUBSCRIBE AND ENJOY 15% OFF YOUR FIRST ONLINE PURCHASE*
Retatrutide – 30MG offers researchers access to one of the most advanced peptides in metabolic science. Acting as a triagonist, it simultaneously activates GLP-1, GIP, and glucagon receptors to produce synergistic effects on weight loss, glucose control, fat metabolism, and energy expenditure.
This 30MG vial is an optimal mid-range dose for researchers running 4–6 week protocols, providing an excellent balance between volume, cost, and flexibility.
Obesity Research:
Demonstrated >24% average bodyweight reduction in human clinical trials
Insulin Sensitivity & Glucose Regulation:
Enhances insulin secretion and improves glycaemic control in diabetic models
Fat Oxidation & Energy Expenditure:
Promotes lipolysis and thermogenesis, preserving lean mass while targeting fat stores
Appetite Suppression:
Reduces hunger through central nervous system pathways, leading to sustained caloric reduction
Reconstitute with 2–3ml of Bacteriostatic Water for Injection (BWFI)
Swirl gently until fully dissolved (do not shake)
Store reconstituted solution at 2–8°C
Use within 30 days of reconstitution for best stability
Ideal for full 1-month research protocols
Flexible for dose titration studies and combination stacks
COA provided; manufactured under strict ISO/GMP standards
Trusted by metabolic researchers for its consistent purity and performance
⚠️ Important Notice: This product is intended strictly for laboratory research use only. Not for human consumption, therapeutic use, or veterinary application.